Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevidipine vs Nicardipine for Postoperative Hypertension (ECLIPSE-NIC)
NCT00093925Phase 3Completed
- Sponsor
- The Medicines Company
- Start
- May 2004
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of clevidipine in hypertension (HTN) (2 arms), sponsored by The Medicines Company. Primary endpoint: Incidence of death, stroke, myocardial infarction, and renal dysfunction at 30 days. Started May 2004; status: completed.
02
Drugs
clevidipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00093925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00093925.